Coya Therapeutics, Inc. (COYA)
COYA Stock Price Chart
Explore Coya Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze COYA price movements and trends.
COYA Company Profile
Discover essential business fundamentals and corporate details for Coya Therapeutics, Inc. (COYA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Dec 2022
Employees
8.00
Website
https://www.coyatherapeutics.comCEO
Arun Swaminathan
Description
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
COYA Financial Timeline
Browse a chronological timeline of Coya Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.02.
Earnings released on 12 Aug 2025
EPS came in at -$0.36 falling short of the estimated -$0.22 by -63.64%, while revenue for the quarter reached $163.62K , missing expectations by -79.11%.
Earnings released on 13 May 2025
EPS came in at -$0.44 matching the estimated -$0.44, while revenue for the quarter reached $257.88K , missing expectations by -90.21%.
Earnings released on 18 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.26 by +30.77%, while revenue for the quarter reached $1.95K , missing expectations by -98.05%.
Earnings released on 6 Nov 2024
EPS came in at -$0.26 surpassing the estimated -$0.41 by +36.59%.
Earnings released on 12 Aug 2024
EPS came in at -$0.19 falling short of the estimated -$0.14 by -35.71%, while revenue for the quarter reached $3.43M , beating expectations by +24.56%.
Earnings released on 9 May 2024
EPS came in at -$0.35 falling short of the estimated -$0.30 by -16.67%, while revenue for the quarter reached $126.84K .
Earnings released on 19 Mar 2024
EPS came in at $0.15 falling short of the estimated $0.26 by -42.31%, while revenue for the quarter reached $6.00M , missing expectations by -19.97%.
Earnings released on 8 Nov 2023
EPS came in at -$0.34 surpassing the estimated -$0.37 by +8.11%.
Earnings released on 8 Aug 2023
EPS came in at -$0.31 surpassing the estimated -$0.32 by +3.13%.
Earnings released on 10 May 2023
EPS came in at -$0.28 surpassing the estimated -$0.43 by +34.88%.
Earnings released on 29 Mar 2023
EPS came in at -$0.42 .
Earnings released on 30 Dec 2022
EPS came in at -$0.52 .
Earnings released on 30 Sept 2022
EPS came in at -$0.42 .
Earnings released on 31 Mar 2022
EPS came in at -$0.26 .
Earnings released on 31 Dec 2021
EPS came in at -$0.25 .
Earnings released on 30 Sept 2021
EPS came in at -$0.14 .
Earnings released on 30 Jun 2021
EPS came in at -$0.37 .
Earnings released on 31 Mar 2021
EPS came in at -$0.37 .
COYA Stock Performance
Access detailed COYA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.